Clinical impact of newer quinolones: influence on normal microflora.
This review article summarizes the published data concerning the impact of ciprofloxacin and norfloxacin on the oropharyngeal and intestinal human microflora. The use of ciprofloxacin and norfloxacin for selective decontamination in compromised patients and for prophylaxis of recurrent urinary tract infections is also reviewed.
Nord
C E
CE
Department of Microbiology, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden.
Edlund
C
C
D001424:Bacterial Infections / Q000517:prevention & control; D002939:Ciprofloxacin / Q000494:pharmacology*; D006801:Humans; D007108:Immune Tolerance; D007413:Intestinal Mucosa / Q000382:microbiology*; D009643:Norfloxacin / Q000494:pharmacology*; D009960:Oropharynx / Q000382:microbiology*; D012008:Recurrence; D014552:Urinary Tract Infections / Q000188:drug therapy
D002939:Ciprofloxacin; D009643:Norfloxacin